Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: Increased risk following diagnosis with hepatitis C infection

International Journal of Drug Policy

Volumn 22, Issue 1, 2011, Pages 63-69

  McDonald, Scott A ^a   Hutchinson, Sharon J ^a,b   Bird, Sheila M ^b,c   Robertson, Chris ^a,b   Mills, Peter R ^d   Dillon, John F ^e   Goldberg, David J ^a  

^a HEALTH PROTECTION SCOTLAND   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^e UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Alcohol; Hepatitis C virus; Hospital admissions; Injecting drug users

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; AGE; ALCOHOL LIVER CIRRHOSIS; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE TREATMENT; FEMALE; FOLLOW UP; HEPATITIS C; HIGH RISK BEHAVIOR; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTEGRATED HEALTH CARE SYSTEM; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SEX DIFFERENCE; UNITED KINGDOM; VIRUS TRANSMISSION;

ALCOHOL DRINKING; ALCOHOL-RELATED DISORDERS; COHORT STUDIES; DATABASES, FACTUAL; DRUG USERS; FEMALE; HEPATITIS C; HOSPITALIZATION; HUMANS; INJECTIONS; MALE; RETROSPECTIVE STUDIES; RISK; RISK FACTORS; RISK-TAKING; SCOTLAND; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 79151472199     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2010.04.003     Document Type: Article

References (31)

1. Andersen P.K., Gill R.D. Cox's regression model for counting processes: A large sample study. Annals of Statistics 1982, 10:1100-1120.
2. Campbell J., Hagan H., Latka M., Garfein R., Golub E., Coady M., et al. High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities. Drug Alcohol Depend 2006, 81(3):259-265.
3. Carstairs V., Morris R. Deprivation and health in Scotland. Health Bulletin 1990, 48(4):162-175.
4. Freeman A., Law M., Kaldor J., Dore G. Predicting progression to cirrhosis in chronic hepatitis C virus infection. Journal of Viral Hepatitis 2003, 10(4):285-293.
5. Glynn R.J., Buring J.E. Ways of measuring rates of recurrent events. British Medical Journal 1996, 312(7027):364-367.
6. Gossop M., Marsden J., Stewart D., Kidd T. The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results. Addiction 2003, 98(3):291-303.
7. Gossop M., Marsden J., Stewart D., Rolfe A. Patterns of drinking and drinking outcomes among drug misusers. 1-Year follow-up results. Journal of Substance Abuse Treatment 2000, 19(1):45-50.
8. Hagan H., Des Jarlais D. HIV and HCV infection among injecting drug users. Mount Sinai Journal Of Medicine 2000, 67(5-6):423-428.
9. Hutchinson S., Bird S., Goldberg D. Influence of alcohol on the progression of hepatitis C virus infection: A meta-analysis. Clinical Gastroenterology and Hepatology 2005, 3(11):1150-1159.
10. Hutchinson S., Bird S., Goldberg D. Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland. Hepatology 2005, 42(3):711-723.
11. Hutchinson S., Roy K., Wadd S., Bird S., Taylor A., Anderson E., et al. Hepatitis C virus infection in Scotland: Epidemiological review and public health challenges. Scottish Medical Journal 2006, 51(2):8-15.
12. Information Services Division (ISD) Drug misuse statistics Scotland 2007 2007, Common Services Agency, Edinburgh.
13. Kendrick S., Clarke J. The Scottish record linkage system. Health Bulletin (Edinburgh) 1993, 51:72-79.
14. Leon D.A., McCambridge J. Liver cirrhosis mortality rates in Britain from 1950 to 2002: An analysis of routine data. Lancet 2006, 367(9504):52-56.
15. McDonald S.A., Donaghy M., Goldberg D.J., Hutchinson S., Robertson C., Bird S., et al. A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland. Statistical Methods in Medical Research 2009, 18(3):271-283.
16. McDonald S.A., Hutchinson S., Bird S., Graham L., Robertson C., Mills P., et al. Association of self-reported alcohol use and hospitalisation for an alcohol-related cause in Scotland: A record-linkage study of 23,183 individuals. Addiction 2009, 104(4):593-602.
17. Micallef J.M., Kaldor J.M., Dore G.J. Spontaneous viral clearance following acute hepatitis C infection: A systematic review of longitudinal studies. Journal of Viral Hepatitis 2006, 13(1):34-41.
18. Monto A., Patel K., Bostrom A., Pianko S., Pockros P., McHutchison J., et al. Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology 2004, 39(3):826-834.
19. Ostapowicz G., Watson K., Locarnini S., Desmond P. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection. Hepatology 1998, 27(6):1730-1735.
20. R Development Core Team R: A language and environment for statistical computing 2006, R Foundation for Statistical Computing, Vienna, Austria.
21. Roy K., Hay G., Andragetti R., Taylor A., Goldberg D., Wiessing L. Monitoring hepatitis C virus infection among injecting drug users in the European Union: A review of the literature. Epidemiology and Infection 2002, 129(3):577-585.
22. Roy K., Hutchinson S., Wadd S., Taylor A., Cameron S., Burns S., et al. Hepatitis C virus infection among injecting drug users in Scotland: A review of prevalence and incidence data and the methods used to generate them. Epidemiology and Infection 2007, 135(3):433-442.
23. Satagopan J., Ben-Porat L., Berwick M., Robson M., Kutler D., Auerbach A. A note on competing risks in survival data analysis. British Journal of Cancer 2004, 91(7):1229-1235.
24. Scottish Government Health Department Hepatitis C action plan for Scotland: Phase II: May 2008-March 2011. 2008, Scottish Government, Edinburgh.
25. Scottish Intercollegiate Guidelines Network (SIGN). (2006, December). Management of hepatitis C. A national clinical guideline (SIGN publication; no. 92, 47pp.). Edinburgh: Scottish Intercollegiate Guidelines Network (SIGN).
26. Shaw L., Taylor A., Roy K., Cameron S., Burns S., Molyneaux P., et al. Establishment of a database of diagnosed HCV-infected persons in Scotland. Commun Dis Public Health 2003, 6(4):305-310.
27. Stein M., Hanna L., Natarajan R., Clarke J., Marisi M., Sobota M., et al. Alcohol use patterns predict high-risk HIV behaviors among active injection drug users. Journal of Substance Abuse Treatment 2000, 18(4):359-363.
28. Taylor A., Allen E., Hutchinson S., Roy K., Goldberg D., Ahmed S., et al. Evaluation of the lord advocate's guidance on the distribution of sterile needles and syringes to injecting drug users 2005, Scottish Executive (Effective Interventions Unit), Edinburgh.
29. Twisk J., Smidt N., de Vente W. Applied analysis of recurrent events: A practical overview. Journal of Epidemiology and Community Health 2005, 59(8):706-710.
30. Watson B., Conigrave K., Wallace C., Whitfield J., Wurst F., Haber P. Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment. Drug and Alcohol Review 2007, 26(3):231-239.
31. Windeler J., Lange S. Events per person year-A dubious concept. British Medical Journal 1995, 310(6977):454-456.